Mersana Therapeutics Raises Profile with Antibody-Drug Conjugate Collaboration with Endo
By Heather Cartwright
Pharma Deals Review: Vol 2012 Issue 3 (Table of Contents)
Published: 16 Mar-2012
DOI: 10.3833/pdr.v2012.i3.1700 ISSN: 1756-7874
Section: Research & Development
Fulltext:
Abstract
Mersana Therapeutics has formed a collaboration with Endo Pharmaceuticals to develop next-generation antibody-drug conjugates (ADCs) against a single, undisclosed cancer target...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS